110 related articles for article (PubMed ID: 3020984)
1. Treatment of cytomegalovirus optic neuritis with dihydroxy propoxymethyl guanine.
Robinson MR; Streeten BW; Hampton GR; Siebold EC; Taylor-Findlay C
Am J Ophthalmol; 1986 Oct; 102(4):533-4. PubMed ID: 3020984
[No Abstract] [Full Text] [Related]
2. Antiviral therapy for cytomegalovirus retinitis in AIDS with dihydroxy propoxymethyl guanine.
Rosecan LR; Stahl-Bayliss CM; Kalman CM; Laskin OL
Am J Ophthalmol; 1986 Apr; 101(4):405-18. PubMed ID: 3008560
[TBL] [Abstract][Full Text] [Related]
3. [Anti-arrhythmic and anti-ischemic action of guanosine-5'-monophosphate].
Eliseev VV; Luk'ianova IIu
Kardiologiia; 1986 Nov; 26(11):100-2. PubMed ID: 3027444
[No Abstract] [Full Text] [Related]
4. Treatment of cytomegalovirus infections in renal transplant recipients with 9-(1,3-dihydroxy-2-propoxymethyl) guanine.
Cantarovich M; Hiesse C; Lantz O; Fassi-Fihri S; Charpentier B; Fries D
Transplantation; 1988 Jun; 45(6):1139-41. PubMed ID: 2837848
[No Abstract] [Full Text] [Related]
5. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome.
Bach MC; Bagwell SP; Knapp NP; Davis KM; Hedstrom PS
Ann Intern Med; 1985 Sep; 103(3):381-2. PubMed ID: 2992335
[No Abstract] [Full Text] [Related]
6. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine).
de Hemptinne B; Lamy ME; Salizzoni M; Cornu C; Mostin J; Fevery J; De Groote V; Otte JB
Transplant Proc; 1988 Feb; 20(1 Suppl 1):652-5. PubMed ID: 2831645
[No Abstract] [Full Text] [Related]
7. Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men.
Masur H; Lane HC; Palestine A; Smith PD; Manischewitz J; Stevens G; Fujikawa L; Macher AM; Nussenblatt R; Baird B
Ann Intern Med; 1986 Jan; 104(1):41-4. PubMed ID: 3000248
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus optic neuritis: characteristics, therapy and survival.
Mansor AM; Li HK
Ophthalmologica; 1995; 209(5):260-6. PubMed ID: 8570149
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of the antiviral precursor 9-(1,3-dihydroxy-2-propoxymethyl)guanine monophosphate by guanylate kinase isozymes.
Boehme RE
J Biol Chem; 1984 Oct; 259(20):12346-9. PubMed ID: 6092331
[TBL] [Abstract][Full Text] [Related]
10. Novel pharmacological strategies in the treatment of life-threatening cytomegalovirus infections. Clinical experience with continuous infusion 9-(1,3-dihydroxy-2-propoxymethyl) guanine.
Whitley RJ; Connell J; Markiewicz MA; Sommadossi JP
Ann N Y Acad Sci; 1990; 616():452-60. PubMed ID: 1964031
[TBL] [Abstract][Full Text] [Related]
11. Resolution of oral hairy leukoplakia during therapy with 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
Newman C; Polk BF
Ann Intern Med; 1987 Sep; 107(3):348-50. PubMed ID: 3039887
[No Abstract] [Full Text] [Related]
12. Comparative effect of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine treatment on cytomegalovirus-induced interstitial pneumonitis in allogeneic bone marrow transplant recipient rats.
Stals FS; Zeytinoglu A; Havennith M; de Clercq E; Bruggeman CA
Transplant Proc; 1993 Feb; 25(1 Pt 2):1248-9. PubMed ID: 8382855
[No Abstract] [Full Text] [Related]
13. Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies.
Collaborative DHPG Treatment Study Group
N Engl J Med; 1986 Mar; 314(13):801-5. PubMed ID: 3005861
[TBL] [Abstract][Full Text] [Related]
14. Presumed cytomegalovirus-associated retrobulbar optic neuritis in a patient after allogeneic stem cell transplantation.
Zheng X; Huang Y; Wang Z; Yan H; Pan S; Wang H
Transpl Infect Dis; 2012 Apr; 14(2):177-9. PubMed ID: 22093546
[TBL] [Abstract][Full Text] [Related]
15. Progressive outer retinal necrosis presenting with isolated optic neuropathy.
Nakamoto BK; Dorotheo EU; Biousse V; Tang RA; Schiffman JS; Newman NJ
Neurology; 2004 Dec; 63(12):2423-5. PubMed ID: 15623719
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid.
Allen LB; Huffman JH; Dan Cook P; Meyer RB; Robins RK; Sidwell RW
Antimicrob Agents Chemother; 1977 Jul; 12(1):114-9. PubMed ID: 196546
[TBL] [Abstract][Full Text] [Related]
17. Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine.
Akula SK; Mansell PW; Ruiz R
Am J Ophthalmol; 1986 May; 101(5):622. PubMed ID: 3010726
[No Abstract] [Full Text] [Related]
18. Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.
Henry K; Cantrill H; Fletcher C; Chinnock BJ; Balfour HH
Am J Ophthalmol; 1987 Jan; 103(1):17-23. PubMed ID: 3026186
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough of cytomegalovirus infection despite 9-(1,3-dihydroxy-2-propoxymethyl)guanine therapy.
Bach MC
Ann Intern Med; 1986 Apr; 104(4):587. PubMed ID: 3006573
[No Abstract] [Full Text] [Related]
20. Cytomegalovirus infection, 9-(1,3-Dihydroxy-2-propoxymethyl)guanine, and Crohn's disease.
Topiel MS; Kutscher JJ; Pilipshen SJ; Quinton KJ
Ann Intern Med; 1986 Aug; 105(2):302-3. PubMed ID: 3014944
[No Abstract] [Full Text] [Related]
[Next] [New Search]
